Your browser doesn't support javascript.
loading
Cefotaxime susceptibility should not be used to predict ceftriaxone susceptibility among Klebsiella oxytoca clinical isolates.
Walkty, Andrew; Adam, Heather J; Karlowsky, James A; Alexander, David C.
Affiliation
  • Walkty A; Department of Medical Microbiology and Infectious Diseases, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada; Shared Health, Winnipeg, Manitoba, Canada; Section of Infectious Diseases, Department of Internal Medicine, Max Rady College of Medicine, University of Manito
  • Adam HJ; Department of Medical Microbiology and Infectious Diseases, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada; Shared Health, Winnipeg, Manitoba, Canada.
  • Karlowsky JA; Department of Medical Microbiology and Infectious Diseases, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada; Shared Health, Winnipeg, Manitoba, Canada.
  • Alexander DC; Department of Medical Microbiology and Infectious Diseases, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada; Cadham Provincial Laboratory, Winnipeg, Manitoba, Canada.
J Glob Antimicrob Resist ; 21: 270-271, 2020 06.
Article in En | MEDLINE | ID: mdl-32339849

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ceftriaxone / Cefotaxime Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: J Glob Antimicrob Resist Year: 2020 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ceftriaxone / Cefotaxime Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: J Glob Antimicrob Resist Year: 2020 Document type: Article